Abstract
Sarcosinemia is an autosomal recessive metabolic trait manifested by relatively high concentrations of sarcosine in blood and urine. Sarcosine is a key intermediate in 1-carbon metabolism and under normal circumstances is converted to glycine by the enzyme sarcosine dehydrogenase. We encountered six families from two different descents (French and Arab), each with at least one individual with elevated levels of sarcosine in blood and urine. Using the “candidate gene approach” we sequenced the gene encoding sarcosine dehydrogenase (SARDH), which plays an important role in the conversion of sarcosine to glycine, and found four different mutations (P287L, V71F, R723X, R514X) in three patients. In an additional patient, we found a uniparental disomy in the region of SARDH gene. In two other patients, we did not find any mutations in this gene. We have shown for the first time that mutations in the SARDH gene are associated with sarcosinemia. In addition, our results indicate that other genes are most probably involved in the pathogenesis of this condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Auray-Blais C, Giguère R, Lemieux B (2003) Newborn urine screening programme in the province of Quebec: an update of 30 years’ experience. J Inherit Metab Dis 26:393–402
Auray-Blais C, Cyr D, Drouin R (2007) Quebec neonatal mass urinary screening programme: from micromolecules to macromolecules. J Inherit Metab Dis 30:515–521
Blom W, Fernandes J (1979) Folic acid dependent hypersarcosinemia. Clin Chim Acta 91:117–125
Castanet M, Mallya U, Agostini M, Schoenmakers E, Mitchell C, Demuth S, Raymond FL, Schwabe J, Gurnell M, Chatterjee VK (2010) Maternal isodisomy for chromosome 9 causing homozygosity for a novel FOXE1 mutation in syndromic congenital hypothyroidism. J Clin Endocrinol Metab 95(8):4031–4036
Clayton-Smith J, Laan L (2003) Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet 40(2):87–95
Deutsch SI, Rosse RB, Long KD, Gaskins B, Mastropaolo J (2006) Rare neurodevelopmental abnormalities of sarcosinemia may involve glycinergic stimulation of a primed N-methyl-d-aspartate receptor. Clin Neuropharmacol 29:361–363
Fragouli E, Wells D, Doshi A, Gotts S, Harper JC, Delhanty JD (2006) Complete cytogenetic investigation of oocytes from a young cancer patient with the use of comparative genomic hybridisation reveals meiotic errors. Prenat Diagn 26(1):71–76
Gerritsen T, Waisman H (1966) Hypersarcosinemia. An inborn error of metabolism. N Engl J Med 275:66
Gerritssen T (1972) Sarcosine Dehydrogenase deficiency, the enzyme defect in hypersarcosinemia. Helv Paediatr Acta 27:33
Harding CO, Williams P, Pflanzer DM, Colwell RE (1992) Sar: a genetic mouse model for human sarcosinemia generated by ethylnitrosourea mutagenesis. Proc Natl Acad Sci USA 89:2644
Israeli O, Gotlieb WH, Friedman E, Goldman B, Ben-Baruch G, Aviram-Goldring A, Rienstein S (2003) Familial vs sporadic ovarian tumors: characteristic genomic alterations analyzed by CGH. Gynecol Oncol 90(3):629–636
Kljuic A, Bazzi H, Sundberg JP et al (2003) Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 113:249–260
Lemieux B, Auray-Blais C, Giguere R, Shapcott D, Scriver CR (1988) Newborn urine screening experience with over one million infants in the Quebec Network of Genetic medicine. J Inherit Metab Dis 11:45
Levy HL, Coulombe JT, Benjamin R (1984) Massachusetts Metabolic Disorders Screening Program: III. Sarcosinemia. Pediatrics 74:509–513
Meissner T, Mayatepek E (1997) Sarcosinaemia in a patient with severe progressive neurological damage and hypertrophic cardiomyopathy. J Inherit Metab Dis 20(5):717–718
Mudd SH, Ebert MH, Scriver CR (1980) Labile methyl group balances in the human: the role of sarcosine. Metabolism 29:707
Scott C (2001) Sarcosinemia. The metabolic and molecular bases of inherited disease, chap 89. McGraw-Hill, New York pp 2057–2063
Scott CR, Clark SH, Teng CC, Swedberg KR (1970) Clinical and cellular studies of sarcosinemia. J Pediatr 77(5):805–811
Wittwer AJ, Wagner C (1980) Identification of folate binding protein of mitochondria as dimethylglycine dehydrogenase. Proc Natl Acad Sci USA 77:4484
Acknowledgments
This work was performed in partial fulfillment of the requirements for a Ph.D. degree of (I BJ), Sackler Faculty of medicine, Tel Aviv University, Israel.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bar-joseph, I., Pras, E., Reznik-Wolf, H. et al. Mutations in the sarcosine dehydrogenase gene in patients with sarcosinemia. Hum Genet 131, 1805–1810 (2012). https://doi.org/10.1007/s00439-012-1207-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-012-1207-x